Company

Sichuan Kelun-Biotech Biopharmaceutical

China

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Sichuan Kelun-Biotech Biopharmaceutical?

Held by 52 covered funds. Sorted by Sichuan Kelun-Biotech Biopharmaceutical’s share of each fund. Holdings as of each fund’s latest SEC filing.

Fund	Category	Share of fund
IPOSRenaissance International IPO		2.0%
KUREKraneShares MSCI All China Health Care Index	Asia-Pacific	1.9%
MCHSMatthews China Discovery Active		1.5%
FPXIFirst Trust International Equity Opportunities		1.3%
MICHXMatthews China Innovators Fund		1.2%
MINVMatthews Asia Innovators Active	Technology	0.8%
MIAPXMatthews Asia Growth Fund	Technology	0.8%
CXSEWisdomTree China ex-State-Owned Enterprises Fund		0.2%
MCHIiShares MSCI China	Asia-Pacific	0.1%
CNQQRayliant-ChinaAMC Transformative China Tech	China	0.1%
FLCHFranklin FTSE China	Asia-Pacific	0.1%
EMGFiShares Emerging Markets Equity Factor	Asia-Pacific	0.1%
LDEMiShares ESG MSCI EM Leaders	ESG & Sustainability	0.1%
EEMOInvesco S&P Emerging Markets Momentum		0.1%
BKFiShares MSCI Bic	Asia-Pacific	0.1%
EMXFiShares ESG Advanced MSCI EM	ESG & Sustainability	0.1%
GXCSPDR S&P China	Asia-Pacific	0.1%
ACWViShares MSCI Global Min Vol Factor		0.1%
EMCRXtrackers Emerging Markets Carbon Reduction and Climate Improvers	ESG & Sustainability	0.0%
SCHESchwab Emerging Markets Equity		0.0%
EEMAiShares MSCI Emerging Markets Asia	Asia-Pacific	0.0%
GSEEGoldman Sachs MarketBeta Emerging Markets Equity	Asia-Pacific	0.0%
AAXJiShares MSCI All Country Asia ex Japan	Asia-Pacific	0.0%
VWOVanguard Emerging Markets Stock Index Fund		0.0%
EEMXSPDR MSCI Emerging Markets Fossil Fuel Reserves Free	Asia-Pacific	0.0%
SSKEXState Street Emerging Markets Equity Index Fund	Asia-Pacific	0.0%
DBEMXtrackers MSCI Emerging Markets Hedged Equity	Asia-Pacific	0.0%
EEMiShares MSCI Emerging Markets	Asia-Pacific	0.0%
XSOEWisdomTree Emerging Markets ex-State-Owned Enterprises Fund	Asia-Pacific	0.0%
FLAXFranklin FTSE Asia ex Japan	Asia-Pacific	0.0%
IEMGiShares Core MSCI Emerging Markets	Asia-Pacific	0.0%
BKEMBNY Mellon Emerging Markets Equity	Asia-Pacific	0.0%
JSTCAdasina Social Justice All Cap Global	ESG & Sustainability	0.0%
BBEMJPMorgan BetaBuilders Emerging Markets Equity	Asia-Pacific	0.0%
JHEMJohn Hancock Multifactor Emerging Markets	Asia-Pacific	0.0%
DFAEDimensional Emerging Core Equity Market	Asia-Pacific	0.0%
IXUSiShares Core MSCI Total International Stock		0.0%
VSGXVanguard ESG International Stock	ESG & Sustainability	0.0%
ACWXiShares MSCI ACWI ex U.S.		0.0%
TEMUXEmerging Markets Equity Fund		0.0%
DBAWXtrackers MSCI All World ex US Hedged Equity		0.0%
VXUSVanguard Total International Stock Index Fund		0.0%
VEUVanguard FTSE All-World Ex-US Index Fund		0.0%
GXUSGoldman Sachs MarketBeta Total International Equity		0.0%
SSGVXState Street Global All Cap Equity ex-U.S. Index Portfolio		0.0%
SPEMSPDR Portfolio Emerging Markets		0.0%
TLTEFlexShares Morningstar Emerging Markets Factor Tilt Index Fund		0.0%
DFEMDimensional Emerging Markets Core Equity 2	Asia-Pacific	0.0%
CWISPDR MSCI Acwi Ex-US		0.0%
VTVanguard Total World Stock Index Fund		0.0%
ACWIiShares MSCI ACWI		0.0%
DFSEDimensional Emerging Markets Sustainability Core 1	ESG & Sustainability	0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Sichuan Kelun-Biotech Biopharmaceutical news

No recent stories about Sichuan Kelun-Biotech Biopharmaceutical.